Programme

08:00 Registration opens

09:00 Opening remarks

09:15 Subcutaneous Delivery of Biologics: Challenges and Solutions
Prof. Samir Mitragotri | Harvard University, USA

09:45 End-to-end considerations for the development of High-Conc biologic drug product from early development to launch
Kishore Ravuri | Roche, Switzerland

10:15 Speed Networking

11:15 Pioneering mAb Subcutaneous Bioavailability Prediction: A Novel Validated Approach
Isabelle Trayton and Belal Hanafy| AstraZeneca, UK

11:45 Predicting clinical bioavailability and efficacy with preclinical interstitial sampling
Thomas Birngruber | Joanneum Research, Austria

12:15 Lunch Break, Exhibition and Posters

13:30 Introduction to the afternoon session

13:45 Discussion panel

14:45 Exhibitors highlights

15:30 Coffee break, Exhibition and Posters

16:00 Harnessing the potential of metallic nanohybrids in cancer theranostics
Clare Hoskins | University of Strathclyde, UK

16:30 Evolution of formulation space for mAbs from IV to SC
Sumantha Dayananda | Ten23 Health, Switzerland

17:00 Concluding remarks

17:10 Conference ends